A Study of Neoadjuvant Hormone Therapy in Patient With Advanced Prostate Cancer Undergoing Radical Prostatectomy.

Clinical trial NCT03971110 · TERMINATED

Trial details

NCT number: NCT03971110
Sponsor: AstraZeneca
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Advanced Prostate Cancer

Start date: 2021-01-28
Primary completion: 2022-11-09
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.